These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30201419)

  • 1. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
    Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
    Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
    Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
    BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
    Chen J; Wang A; Ji K; Bu Z; Ji J
    BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.
    Deng HY; Li G; Luo J; Li XR; Alai G; Lin YD
    World J Surg; 2018 Aug; 42(8):2428-2436. PubMed ID: 29340724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    Ma F; Wang B; Xue L; Kang W; Li Y; Li W; Liu H; Ma S; Tian Y
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2135-2142. PubMed ID: 32306127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
    Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
    Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
    Morita M; Taguchi K; Kagawa M; Nakanoko T; Uehara H; Sugiyama M; Ota M; Ikebe M; Sugimachi K; Esaki T; Toh Y
    Int J Clin Oncol; 2020 May; 25(5):842-850. PubMed ID: 32036480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology Shift in Esophageal Cancer Between Biopsies and Resections After Neoadjuvant Therapy: A Pilot Study.
    Hou T; Yang Z; Zhang Q; Zhang X; Liao X; Lin J
    Int J Surg Pathol; 2024 Aug; 32(5):920-925. PubMed ID: 37899731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
    Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers?
    Hanna GB; Boshier PR; Knaggs A; Goldin R; Sasako M
    Arch Surg; 2012 Aug; 147(8):738-45. PubMed ID: 22911070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
    Seesing MFJ; van der Veen A; Brenkman HJF; Stockmann HBAC; Nieuwenhuijzen GAP; Rosman C; van den Wildenberg FJH; van Berge Henegouwen MI; van Duijvendijk P; Wijnhoven BPL; Stoot JHMB; Lacle M; Ruurda JP; van Hillegersberg R;
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31220859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
    J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
    Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
    World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.